# Study to Evaluate the Value of the Follow-up of CALCIneurin Activity to MOdulate Calcineurin Inhibitors-induced Immunosuppression in Lung Transplantation

> **NCT02897895** · NA · UNKNOWN · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 134 (estimated)

## Conditions studied

- Lung Diseases

## Interventions

- **BIOLOGICAL:** levels of CNI in whole blood
- **BIOLOGICAL:** Calcineurin activity (CN-a) in peripheral blood mononuclear cells (PBMCs)

## Key facts

- **NCT ID:** NCT02897895
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-12
- **Primary completion:** 2021-12
- **Final completion:** 2022-12
- **Target enrollment:** 134 (ESTIMATED)
- **Last updated:** 2016-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02897895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02897895, "Study to Evaluate the Value of the Follow-up of CALCIneurin Activity to MOdulate Calcineurin Inhibitors-induced Immunosuppression in Lung Transplantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02897895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*